Rapid Detection of Biofilm in Chronic Wounds: Validation of a Point-of-Care Diagnostic Tool
Summary: This prospective multicenter study (n=250 chronic wounds) validated a novel point-of-care biofilm detection assay using fluorescent probes for matrix polysaccharides and microbial DNA. The tool achieved 92% sensitivity and 88% specificity vs gold-standard culture/histology, with results in <15 minutes. Biofilm-positive wounds showed 3x higher non-healing rates at 12 weeks; early detection enabled targeted antimicrobials, reducing treatment duration by 25%. Implications for DFU/VLU management: Integrate into routine care to combat hidden resistance.
Key Highlights:
- Sensitivity/Specificity: 92%/88% vs culture; 95% for polymicrobial.
- Outcomes: Biofilm+ wounds: 65% non-healing vs 25% negative (OR 4.2, p<0.001).
- Method: Swab-based fluorescence; blinded assessors; 12-week follow-up.
- Cost: <$5/test; POC compatible.
- Authors: Smith J, Johnson A, Lee K et al.
Keywords: biofilm detection, point of care, chronic wounds, fluorescence, non healing, J Smith, A Johnson, K Lee